Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -18.251% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCNC(=O)c1onc(CSc2ccc(F)c(F)c2)c1C(=O)NCCC
(b) CCCCOc1ccc(S(=O)(=O)NNC(=O)c2cc3ccccc3o2)cc1
(c) O=C(O)Cn1cc2c(n1)CCCCC2
Answer: a. CCCNC(=O)c1onc(CSc2ccc(F)c(F)c2)c1C(=O)NCCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1onc(CSc2ccc(F)c(F)c2)c1C(=O)NCCC
CCCNC(=O)c1onc(CSc2ccc(F)c(F)c2)c1C(=O)NCCC
3-[(3,4-difluorophenyl)sulfanylmethyl]-4-N,5-N-dipropyl-1,2-oxazole-4,5-dicarboxamide